-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Podcast
Business Insights: Agile Brand Promotion for the Emerging Biopharma Market
Mar 29, 2023
Over the past several years, there’s been a marked increase in the volume of emerging biopharma (EBP) companies facilitating their own product launches. In today’s turbulent market, one of the ways that EBP leaders can make a difference in their launch success is focusing on investment optimization – making sure that they’re smart about how their limited resources (digital, field-force, etc.) are deployed. In this episode of our ongoing podcast series, Agile Brand Promotion for the Emerging Biopharma Market, Susan Kitlas VP, Precommercial Segment, joins our host, Matthew Smith, Sr. Principal, Consulting Services, for an in-depth discussion on new commercial models for the EBP market.
Did you enjoy the podcast? Visit our Agile Brand Promotion podcast series homepage to access additional episodes!
Related solutions
Brand & Marketing
Grow your brand, now and through patent expiry
Emerging Biopharma
Flexible solutions. Responsive teams. Data-driven insights.